Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PARATHYROID HORMONE Cause Hypercalcaemia? 131 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Hypercalcaemia have been filed in association with PARATHYROID HORMONE (NATPARA (parathyroid hormone)). This represents 2.9% of all adverse event reports for PARATHYROID HORMONE.

131
Reports of Hypercalcaemia with PARATHYROID HORMONE
2.9%
of all PARATHYROID HORMONE reports
0
Deaths
68
Hospitalizations

How Dangerous Is Hypercalcaemia From PARATHYROID HORMONE?

Of the 131 reports, 68 (51.9%) required hospitalization, and 18 (13.7%) were considered life-threatening.

Is Hypercalcaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PARATHYROID HORMONE. However, 131 reports have been filed with the FAERS database.

What Other Side Effects Does PARATHYROID HORMONE Cause?

Recalled product (900) Hypocalcaemia (784) Blood calcium decreased (703) Paraesthesia (364) Muscle spasms (357) Headache (257) Drug ineffective (217) Blood calcium increased (212) Nausea (201) Inappropriate schedule of product administration (195)

What Other Drugs Cause Hypercalcaemia?

RITUXIMAB (857) METHOTREXATE (803) ADALIMUMAB (663) TOCILIZUMAB (618) ABATACEPT (612) ETANERCEPT (602) DENOSUMAB (599) ALENDRONATE (594) INFLIXIMAB (594) LEFLUNOMIDE (585)

Which PARATHYROID HORMONE Alternatives Have Lower Hypercalcaemia Risk?

PARATHYROID HORMONE vs PARECOXIB PARATHYROID HORMONE vs PARICALCITOL PARATHYROID HORMONE vs PARITAPREVIR PARATHYROID HORMONE vs PAROXETINE PARATHYROID HORMONE vs PAROXETINE\PAROXETINE

Related Pages

PARATHYROID HORMONE Full Profile All Hypercalcaemia Reports All Drugs Causing Hypercalcaemia PARATHYROID HORMONE Demographics